SCHEDULE 13G

Company

Viridian Therapeutics, Inc.\DE

Filed

April 3, 2017

Accession Number

0001683168-17-000777

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →